GPR149
Basic information
Region (hg38): 3:154334943-154430190
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR149 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 42 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 2 | 0 |
Variants in GPR149
This is a list of pathogenic ClinVar variants found in the GPR149 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-154337714-T-G | not specified | Uncertain significance (Jul 27, 2023) | ||
3-154337815-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-154337937-C-T | not specified | Uncertain significance (May 26, 2023) | ||
3-154337946-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
3-154337964-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
3-154338106-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
3-154338151-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
3-154338201-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
3-154338265-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
3-154338270-C-T | not specified | Uncertain significance (May 10, 2022) | ||
3-154421067-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-154421104-T-A | not specified | Uncertain significance (Apr 12, 2022) | ||
3-154421169-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
3-154421172-C-T | not specified | Likely benign (Jul 05, 2022) | ||
3-154421190-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
3-154421191-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
3-154421194-C-A | not specified | Uncertain significance (Jul 07, 2024) | ||
3-154421204-G-T | not specified | Uncertain significance (Dec 03, 2021) | ||
3-154421221-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
3-154421242-T-C | not specified | Uncertain significance (Jun 28, 2022) | ||
3-154421258-T-G | Hypertrophic cardiomyopathy | Uncertain significance (-) | ||
3-154421280-G-T | not specified | Uncertain significance (Dec 28, 2022) | ||
3-154421326-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
3-154421326-G-T | not specified | Uncertain significance (Mar 13, 2023) | ||
3-154421334-C-G | not specified | Uncertain significance (Aug 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR149 | protein_coding | protein_coding | ENST00000389740 | 4 | 92044 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.37e-9 | 0.586 | 124685 | 0 | 112 | 124797 | 0.000449 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.932 | 450 | 398 | 1.13 | 0.0000192 | 4773 |
Missense in Polyphen | 138 | 132.48 | 1.0416 | 1638 | ||
Synonymous | -1.68 | 193 | 165 | 1.17 | 0.00000837 | 1505 |
Loss of Function | 1.20 | 16 | 22.1 | 0.725 | 0.00000101 | 287 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00153 | 0.00153 |
Ashkenazi Jewish | 0.000100 | 0.0000993 |
East Asian | 0.00111 | 0.00111 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000284 | 0.000282 |
Middle Eastern | 0.00111 | 0.00111 |
South Asian | 0.000266 | 0.000261 |
Other | 0.000340 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Orphan receptor.;
Recessive Scores
- pRec
- 0.0968
Intolerance Scores
- loftool
- 0.290
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.8
Haploinsufficiency Scores
- pHI
- 0.153
- hipred
- N
- hipred_score
- 0.275
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.201
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr149
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype;
Gene ontology
- Biological process
- preantral ovarian follicle growth;antral ovarian follicle growth;neuropeptide signaling pathway;negative regulation of ovulation
- Cellular component
- integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;melanin-concentrating hormone receptor activity;peptide binding;neuropeptide binding